ET
ELIXIRGEN THERAPEUTICS, INC.
SEC filingBiotechnology · Baltimore, MD
Amount raised$4Msold at filing
Total offering$4M
Investors in the raise1count reported to the SEC
FiledNov 13, 2025first sale Oct 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
HIROAKI KOBAYASHIDirector
THOMAS WHITEDirector
JEFFREY CLELANDDirector
MINORU KODirector
SHAUNA CALLAHANDirector
AKIHIRO KOExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.